Charles R. Romp, EVP, Commercial at SEATTLE GENETICS INC /WA (SGEN), sold 2,266 shares at $155.69 ($353K) on 2020-08-31, disclosed to the SEC on 2020-09-02.
Open-market sale of $353k SGEN by EVP, Commercial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $155.69 | 555 | $86K | 24.5% |
| 2 | $155.69 | 555 | $86K | 24.5% |
| 3 | $155.69 | 578 | $90K | 25.5% |
| 4 | $155.69 | 578 | $90K | 25.5% |
| Total | $155.69 avg | 2,266 | $353K | 100% |
| Filing → |
| SGEN | SELL | 2023-08-30 | $90K | — | Filing → |
| SGEN | SELL | 2023-07-05 | $273K | — | Filing → |
| SGEN | SELL | 2023-05-18 | $133K | — | Filing → |